Obesity is one of the greatest public health issues facing the NHS and weight loss drugs, such as tirzepatide, are an important tool in helping people lose weight while also reducing the risk of other ...

Obese people ‘will have to wait’ for weight loss jab Mounjaro, NHS officials warn - Mounjaro to be rolled out to only ...

Final draft guidance published by Nice shows NHS England requested that Mounjaro is rolled out over a period of 12 years. The ...

Concerns have been raised over patients facing long waits in emergency departments not being given time-sensitive medication ...

However the NHS spending watchdog has announced Mounjaro will only be given to 220,000 people in England during the first three years - despite 3.4 million people being eligible for it. Trials have ...

Though flavonoids may confer antioxidant, anti-inflammatory, and vasodilatory benefits, the relationship between chocolate ...

Fewer than one in ten patients who meet the criteria for Mounjaro will be given it by the health service over the next three ...

Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...

After just five months in office, Sir Keir Starmer will unveil a major reset designed to persuade voters that ministers are ...

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

Alder Hey Children’s NHS Foundation Trust said criminals gained unlawful access to data through a digital gateway last ...